Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan

By Nakamura Yu   Kitamura Shin   Homma Akira   Shiosakai Kazuhito   Matsui Daiju  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 913-925

Informa Healthcare

Access to resources Recommend Favorite

Nicergoline in the long term treatment of mild or moderate senile dementia. A multicenter double-blind, randomized, placebo-controlled trial

By Nicergoline Dementia Long Term Study Italian Group   Battaglia A.   Annoni K.   Pamparana F.   De Paolis C.   Bonura M.L.   Stekke W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 383-383

Elsevier

Access to resources Recommend Favorite

Efficacy of FPF 1070 (Cerebrolysin) in Patients with Alzheimer's Disease: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial

By Shifu X.   Heqin Y.   Peifen Y.  

Clinical Drug Investigation, Vol. 19, Iss. 1, 2000-01 ,pp. : 43-53

Adis International

Access to resources Recommend Favorite

Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

By Askari Neda  

CNS Drugs, Vol. 26, Iss. 10, 2012-10 ,pp. : 883-892

Adis International

Access to resources Recommend Favorite

Diclofenac Epolamine plus Heparin Plaster versus Diclofenac Epolamine Plaster in Mild to Moderate Ankle Sprain: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicentre, Phase III Trial

By Costantino Cosimo  

Clinical Drug Investigation, Vol. 31, Iss. 1, 2011-01 ,pp. : 15-26

Adis International

Access to resources Recommend Favorite